Mahesh M
★    

India,
2014-12-11 14:45
(3416 d 21:49 ago)

Posting: # 14054
Views: 2,717
 

 MDIs formulation [Regulatives / Guidelines]

Dear All,

Can anyone suggest me what are the reasons for maintaining 30 sec gap between two inhalation (Puffs) in MDIs formulation? (Mentioned in SPC or PI)
And if we maintained the 30 sec gap between two puffs then chances miss to characterize the initial rate of absorption of the drug and the peak concentrations.

Regards
ElMaestro
★★★

Denmark,
2014-12-11 14:54
(3416 d 21:40 ago)

@ Mahesh M
Posting: # 14055
Views: 2,272
 

 MDIs formulation

Dear Mahesh M,

❝ Can anyone suggest me what are the reasons for maintaining 30 sec gap between two inhalation (Puffs) in MDIs formulation? (Mentioned in SPC or PI)


Inhaling consistently and correctly sounds like a trivial task but is in fact quite difficult. Especially when multiple inhalations are needed. A 30sec interval between any two inhalations adds some reassurance and is likely good for the efficacy. For the clinical staff it is a great help too that they don't need to rush every inhalation through. As you will see when you start the study 30secs is not a lot in practice.


❝ And if we maintained the 30 sec gap between two puffs then chances miss to characterize the initial rate of absorption of the drug and the peak concentrations.


Yes, if you are working on e.g. Formoterol or Salmeterol MDI then you'll find it difficult to capture the Cmax properly. You will sometimes see it on the first blood sample. There is no good way around it, for example you can't just ask the clinical to "work faster", so you'll have to live with it.

Pass or fail!
ElMaestro
Mahesh M
★    

India,
2014-12-12 07:57
(3416 d 04:36 ago)

@ ElMaestro
Posting: # 14059
Views: 2,212
 

 MDIs formulation

Hi ElMaestro,

Thanks for your responce.

❝ Especially when multiple inhalations are needed. A 30sec interval between any two inhalations adds some reassurance and is likely good for the efficacy.


do you have any reference for the same?


As you will see when you start the study 30secs is not a lot in practice.

We have to mention dosing procedure in protocol and if we not mention about 30 sec gap between two puffs, regulatory agency may ask for the same (means not follow the SPC with regards of dosing instruction)

please share your thoughts on that.

Regards
ElMaestro
★★★

Denmark,
2014-12-12 10:36
(3416 d 01:58 ago)

@ Mahesh M
Posting: # 14061
Views: 2,175
 

 MDIs formulation

Hi Mahesh M,

❝ do you have any reference for the same?


I don't.
I think it is a rather practical matter.

❝ We have to mention dosing procedure in protocol and if we not mention about 30 sec gap between two puffs, regulatory agency may ask for the same (means not follow the SPC with regards of dosing instruction)


Yes, you can e.g. write in your protocol that you are dosing approx. 30 secs apart and that t=0 is when the first puff is given.
By the way you don't always need to do everything strictly as per SPC for EU submissions. Other examples of SPC deviations in OIP studies include nose clips and total doses.

Good luck with your study.

Pass or fail!
ElMaestro
UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,663 registered users;
95 visitors (0 registered, 95 guests [including 8 identified bots]).
Forum time: 13:34 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5